Shoulder PainNCT07316946
Effects of Neuromuscular Taping on Shoulder Pain and Function in Pitchers: A Clinical Trial
A study testing Experimental Group in people with Shoulder Pain, run by Sandra Jiménez-del-Barrio at 1 site in Spain.
Trial summary
Effects of Neuromuscular Taping on Shoulder Pain and Function in Pitchers: A Clinical Trial Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Shoulder Pain
- What is being tested?
- Experimental Group
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 62 participants
- Where
- 1 siteSpain
- Study dates
- 13 Feb 2026to 30 Jul 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- age over 18 years
- compete in a sport that involves overhead movement patterns
- train at least 2 hours per week
- shoulder pain lasting more than six weeks
- shoulder pain related to sports activity
- understand Spanish fluently enough to complete the questionnaire assessment.
Who cannot join
- presence of red flags that could suggest fractures, dislocations, or complete tendon ruptures, among others
- neurological pathologies
- other severe pathologies such as inflammatory arthritis, frozen shoulder
- having received corticosteroid injections or physiotherapy treatment in the last six months
- presence of previous surgeries
- pregnancy
- cognitive deficits that could limit the comprehension of the questionnaires or the physical evaluation
- skin problems that would be a contraindication for any type of bandage.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Spain1 site
Faculty of Health Sciences
Soria, Soria, 42004
Sandra Jiménez del Barrio, Phd, 975129166, sandra.jimenez.barrio@uva.es
About this study
Effects of Neuromuscular Taping on Shoulder Pain and Function in Pitchers: A Clinical Trial
Read the detailed description
Randomized clinical trial 2 arms
- Conditions
- Shoulder Pain
- Being tested
- Experimental Group, Placebo Group
- Keywords
- neuromuscular taping, pain, function, shoulder
- Medical subject headings
- Shoulder Pain, Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Experimental GroupOther
The experimental group will receive a multilayer neuromuscular taping application using kinesiotape, consisting of the placement of two longitudinal strips in the direction of the lower trapezius, applied with tension close to 100% of the tape's elastic capacity. During the application, participants will be asked to activate the scapular depressor and retractor muscles.
Additionally, two other longitudinal strips will be applied from the anterior portion of the humeral head toward the scapular spine, also with tension close to 100%. During this application, participants will be asked to activate the rotator cuff through a posteroanterior push of the humeral head.
Placebo GroupOther
The placebo group will receive the same taping, with an identical arrangement of the strips, but without applying any tension (0%) to them. In addition, participants will not receive any instructions regarding muscle activation during the application. This placebo taping model has been used in previous studies, supporting its methodological validity.
| Study group | Role | What they receive |
|---|---|---|
| Placebo group | Placebo comparator | The placebo group will receive the same bandage, with the same strip arrangement, but without any tension (0%) applied to any of the strips. Furthermore, participants will not receive any instructions for muscle activation during application. This placebo technique has been used in previous studies, supporting its methodological validity. Receives: Other: Placebo Group |
| Experimental group | Experimental | The experimental group will receive neuromuscular taping with kinesiology tape, consisting of two longitudinal strips applied along the lower trapezius muscle, with a tension close to 100% of the tape's elastic capacity. During application, the participant will be asked to activate the scapular depressor and retractor muscles.
Additionally, two more longitudinal strips will be applied from the anterior portion of the humeral head towards the scapular spine, also with a tension close to 100%. During this application, the participant will be asked to activate the rotator cuff by applying a posteroanterior push to the humeral head. Receives: Other: Experimental Group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Actual Pain Intensity
Pain intensity will be assessed using a 10-cm visual analog scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will be asked to rate the intensity of pain experienced at the time of measurement
Measured: Baseline, after 30 minutes of the intervention and 72 hours after intervencion
Pain Intensity during the arm elevation
Pain intensity will be assessed using a 10-cm visual analog scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will be asked to rate the intensity of pain experienced during arm elevation.
Measured: Baseline, 30 minutes after intervention and 72 hours after intervention
Secondary outcomes (3)
Static Scapular Position
Scapular position will be measured using an anterior/posterior scale. This static position will be recorded while standing, using a digital clinometer installed on a smartphone (Clinometer app). The inclinometer will be positioned directly over the scapular spine in the direction of the infraglenoid fossa.
Measured: Baseline, 30 minutes after intervention and 72 hours after intervention
Range of Motion
Pain-free ROM during shoulder flexion, adduction, internal rotation, and external rotation will be measured following the protocol described by Shin et al.Participants will be instructed to flex the affected arm as far as possible, keeping the thumb pointing toward the ceiling. For adduction measurement, the patient will be placed in the side-lying position, and the evaluator will manually stabilize the scapula against the patient's thorax, allowing the arm to hang horizontally in adduction. For internal and external rotation, participants will be positioned supine with the shoulder abducted to 90°, the elbow flexed to 90°, and the forearm in a neutral position. A rolled towel will be placed under the humerus to maintain shoulder alignment. Participants will be asked to rotate their arm until pain onset or until scapular movement is observed. Three attempts of each movement will be recorded, and the mean range of motion (ROM) will be used for statistical analysis.
Measured: Baseline, 30 minutes after intervention and 72 hours after intervention
Functional Capacity
Functional capacity will be assessed using the SPADI questionnaire. The SPADI is a patient-reported outcome measure designed to assess shoulder pain and functional disability. It consists of 13 items divided into two domains: pain and disability. The total score will be calculated by summing both domains and converting the result to a scale of 0 to 100, where higher scores indicate greater pain and disability.
Measured: Baseline, 30 minutes after intervention and 72 hours after intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jan 2026
- Study start13 Feb 2026 (estimated)
- Primary completion20 Jun 2026 (estimated)
- Study completion30 Jul 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Shoulder PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized clinical trial 2 arms
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 62 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sandra Jiménez-del-Barrio
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Sandra Jiménez-del-Barrio, University of Valladolid
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07316946
- Sponsor's protocol ID
- REF CEIm
- Status last verified
- Dec 2025
- First submitted
- 9 Dec 2025
- Last updated
- 5 Jan 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 5 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Neuromuscular Taping on Shoulder Pain and Function in Pitchers: A Clinical Trial
- ClinicalTrials.gov ID
- NCT07316946
- Acronym / sponsor ID
- REF CEIm
- Conditions
- Shoulder Pain
- Keywords
- neuromuscular taping, pain, function, shoulder
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 62 participants (estimated)
- Lead sponsor
- Sandra Jiménez-del-BarrioUniversity, hospital or other
- Study start
- 13 Feb 2026 (estimated)
- Primary completion
- 20 Jun 2026 (estimated)
- Study completion
- 30 Jul 2026 (estimated)
- First posted
- 5 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Effects of Neuromuscular Taping on Shoulder Pain and Function in Pitchers: A Clinical Trial
Detailed description
Randomized clinical trial 2 arms
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
- Model description
- Randomized clinical trial 2 arms
| Arm | Type | Receives |
|---|---|---|
| Placebo group | Placebo comparator | Other: Placebo GroupThe placebo group will receive the same bandage, with the same strip arrangement, but without any tension (0%) applied to any of the strips. Furthermore, participants will not receive any instructions for muscle activation during application. This placebo technique has been used in previous studies, supporting its methodological validity. |
| Experimental group | Experimental | Other: Experimental GroupThe experimental group will receive neuromuscular taping with kinesiology tape, consisting of two longitudinal strips applied along the lower trapezius muscle, with a tension close to 100% of the tape's elastic capacity. During application, the participant will be asked to activate the scapular depressor and retractor muscles. Additionally, two more longitudinal strips will be applied from the anterior portion of the humeral head towards the scapular spine, also with a tension close to 100%. During this application, the participant will be asked to activate the rotator cuff by applying a posteroanterior push to the humeral head. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- age over 18 years
- compete in a sport that involves overhead movement patterns
- train at least 2 hours per week
- shoulder pain lasting more than six weeks
- shoulder pain related to sports activity
Key exclusion criteria (8 listed)
- presence of red flags that could suggest fractures, dislocations, or complete tendon ruptures, among others
- neurological pathologies
- other severe pathologies such as inflammatory arthritis, frozen shoulder
- having received corticosteroid injections or physiotherapy treatment in the last six months
- presence of previous surgeries
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Experimental GroupThe experimental group will receive a multilayer neuromuscular taping application using kinesiotape, consisting of the placement of two longitudinal strips in the direction of the lower trapezius, applied with tension close to 100% of the tape's elastic capacity. During the application, participants will be asked to activate the scapular depressor and retractor muscles. Additionally, two other longitudinal strips will be applied from the anterior portion of the humeral head toward the scapular spine, also with tension close to 100%. During this application, participants will be asked to activate the rotator cuff through a posteroanterior push of the humeral head. | Other | Experimental group |
| Placebo GroupThe placebo group will receive the same taping, with an identical arrangement of the strips, but without applying any tension (0%) to them. In addition, participants will not receive any instructions regarding muscle activation during the application. This placebo taping model has been used in previous studies, supporting its methodological validity. | Other | Placebo group |
Primary outcome
Actual Pain Intensity
Time frame: Baseline, after 30 minutes of the intervention and 72 hours after intervencion
Pain intensity will be assessed using a 10-cm visual analog scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will be asked to rate the intensity of pain experienced at the time of measurement
Pain Intensity during the arm elevation
Time frame: Baseline, 30 minutes after intervention and 72 hours after intervention
Pain intensity will be assessed using a 10-cm visual analog scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will be asked to rate the intensity of pain experienced during arm elevation.
3 secondary outcomes
Static Scapular Position
Time frame: Baseline, 30 minutes after intervention and 72 hours after intervention
Range of Motion
Time frame: Baseline, 30 minutes after intervention and 72 hours after intervention
Functional Capacity
Time frame: Baseline, 30 minutes after intervention and 72 hours after intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Jan 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Shoulder Pain
Recruiting
Effects of Cervicothoracic Mobilization in Patients With Supraspinatus Tendinitis
Rotator Cuff Tendonitis
Recruiting
Hybrid mHealth and Telerehabilitation vs Conventional Physiotherapy for Subacromial Pain Syndrome
Subacromial Pain Syndrome
Not yet recruiting
Magnesium Sulphate as an Adjuvant in Combined Costoclavicular Block and Suprascapular Block Versus Interscalene Block for Ambulatory Shoulder Arthroscopy
Postoperative Pain, Shoulder Arthroscopy
Active, not recruiting
Effects of Injection Combined With Spencer Technique on Painful Frozen Shoulder
Frozen Shoulder
Not yet recruiting
Laser Therapy Versus Transcutaneous Electical Nerve Stimulation at Hemiplegic Shoulder Pain
Hemiplegic Shoulder Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Experimental Group in people with Shoulder Pain, run by Sandra Jiménez-del-Barrio at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 5 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Actual Pain Intensity (time frame: Baseline, after 30 minutes of the intervention and 72 hours after intervencion). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2026.